The Subsequent Nice Overdose-Reversing Drug May Already Exist
Critics say the Schedule I classification is heavy-handed, based mostly on worry reasonably than proof. “It bypasses science,” says Maritza Perez, a director on the Drug Coverage Alliance, a non-profit centered on drug coverage reform.…